Cancer chemoprevention: scientific promise, clinical uncertainty.
about
Variations in Antioxidant Genes and Male InfertilityMolecular cancer prevention: Current status and future directionsStress-activated cap'n'collar transcription factors in aging and human diseaseDysfunctional KEAP1-NRF2 interaction in non-small-cell lung cancerLAS0811: from combinatorial chemistry to activation of antioxidant response element.Triterpenoids CDDO-methyl ester or CDDO-ethyl amide and rexinoids LG100268 or NRX194204 for prevention and treatment of lung cancer in mice.The rexinoid LG100268 and the synthetic triterpenoid CDDO-methyl amide are more potent than erlotinib for prevention of mouse lung carcinogenesisSynthetic triterpenoid induces 15-PGDH expression and suppresses inflammation-driven colon carcinogenesis.Apoptosis induced by ozone and oxysterols in human alveolar epithelial cells.The cystine/glutamate antiporter system x(c)(-) in health and disease: from molecular mechanisms to novel therapeutic opportunities.Dietary chalcones with chemopreventive and chemotherapeutic potential.Targeting NRF2 signaling for cancer chemoprevention.The Akt inhibitor ISC-4 activates prostate apoptosis response protein-4 and reduces colon tumor growth in a nude mouse model.PI3K target based novel cyano derivative of betulinic acid induces its signalling inhibition by down-regulation of pGSK3β and cyclin D1 and potentially checks cancer cell proliferation.CDDO-methyl ester delays breast cancer development in BRCA1-mutated mice.Keap1/Nrf2 signaling regulates oxidative stress tolerance and lifespan in DrosophilaPolyphenols from green tea and pomegranate for prevention of prostate cancer.Regulatory potential for concerted modulation of Nrf2- and Nfkb1-mediated gene expression in inflammation and carcinogenesisMultiple molecular and cellular mechanisms of action of lycopene in cancer inhibition.Beta-glucans as immunostimulant in vertebrates and invertebrates.Traditional Chinese medicinal formula Si-Wu-Tang prevents oxidative damage by activating Nrf2-mediated detoxifying/antioxidant genes.Global assessment of genetic variation influencing response to retinoid chemoprevention in head and neck cancer patients.Natural sulforaphane as a functional chemopreventive agent: including a review of isolation, purification and analysis methods.Targeting the PI3K/Akt/mTOR axis by apigenin for cancer prevention.Nutraceuticals for prostate cancer chemoprevention: from molecular mechanisms to clinical application.Progress in nanotechnology based approaches to enhance the potential of chemopreventive agents.Chemopreventive effect of 18β-glycyrrhetinic acid via modulation of inflammatory markers and induction of apoptosis in human hepatoma cell line (HepG2).Genetic and epigenetic cancer chemoprevention on molecular targets during multistage carcinogenesis.STAT3 targeting by polyphenols: Novel therapeutic strategy for melanoma.Synthesis, pharmacophores, and mechanism study of pyridin-2(1H)-one derivatives as regulators of translation initiation factor 3A.Hepatoprotective Effect of Aqueous Extract from the Seeds of Orychophragmus violaceus against Liver Injury in Mice and HepG2 CellsCancer-Related Constituents of Strawberry Jam as Compared with Fresh Fruit.Modulatory effects of curcumin in conjunction with piperine on benzo(a)pyrene-mediated DNA adducts and biotransformation enzymes.6-(Methylsulfonyl) hexyl isothiocyanate as potential chemopreventive agent: molecular and cellular profile in leukaemia cell lines.Hypermethylation of adenomatous polyposis coli gene promoter is associated with novel Wnt signaling pathway in gastric adenomas.Apoptosis: the suicide solution in cancer treatment and chemoprevention.Toward an understanding of the role of a catechol moiety in cancer chemoprevention: The case of copper- and o-quinone-dependent Nrf2 activation by a catechol-type resveratrol analog.
P2860
Q26775995-5B749683-D03C-40F5-A1C5-BAA4C001389EQ26797207-3A4A4DE4-F3EA-43DF-8E16-F454A4F57940Q28384783-7D68598B-2008-49BD-960C-28C6DC6F6217Q28469051-20CAF4F0-D658-4A5E-A317-E39367AF845BQ33507900-FBC06B23-8A77-4F82-91C1-178643E537D3Q33636771-4CB24B20-68F0-4BE1-841F-8E5EFCA78F9DQ33677828-0C7BCE1E-3432-41BA-80A2-7F5B403588DEQ33872540-2975716B-5E44-4B49-ABBD-041751FAFEF0Q34248712-59D37AA1-47F8-40D4-A8C6-06C78ADE0A32Q34279067-44562858-829D-4650-AA8A-111DA770A37CQ34975832-846FB7FF-7FEF-4B70-AC79-4AD8A6431C29Q35001318-1A137598-2D8F-4753-AD93-9FDF3954F622Q35091427-BF83A8AF-38E5-41E5-AE5F-CA4F2D7A066DQ35642615-ADA5DC99-8535-4C77-A494-2ABCBD61D29AQ35656210-048A6858-80DB-4C72-8F58-0B794D20F347Q36481370-5E035081-22FA-49E6-9CFB-5B8A4D2A19DCQ36610398-9747BC5D-9DB3-432F-B4E9-32BA6BE6DC5AQ37023880-19BADD4F-4417-477F-9941-CBC3BEBAAE61Q37077880-922826A5-BCDF-4365-BB83-5461728A87EAQ37514264-3DF2BB01-6C99-4036-A672-5A07352B10ACQ37594635-07882977-7C9F-44A6-8C1A-4E4902BFBF58Q37638788-7DDB8700-DF94-41CF-AAEA-4745EF7F6110Q37937673-71DE55AE-A988-446D-B90C-0CCF8F380187Q38070195-E408A05C-783D-41BA-A04A-149733A5F063Q38139567-F5EB8535-4500-4292-A0D5-BAE439FCA656Q38161333-09A327F5-440A-4377-AACE-8F43593CDF90Q38775227-D2D34F58-E65A-43F6-8878-868101A1CF36Q38931011-8631B3B4-C685-433D-B6B7-06B67295C184Q39023307-00914252-C313-4BF0-BD13-85235EE5C78AQ39108027-337E5275-CC96-4A2C-B147-50063B96E343Q41034125-D9EBE08A-1C3F-40C6-A4CC-00A30D23AC2DQ43066467-7A3CB6C1-88AD-4721-A526-074CAA4058F7Q47874549-87A36C96-8DEC-46BF-8849-0BE05440B4BAQ49707077-6CE50D8C-8633-41B2-8842-36B008F439DAQ53268565-7E282179-3B2C-4D0C-A157-A08A18743422Q53345637-F8913BDE-1874-4D75-BC28-5E8DC38C0423Q54250036-7117864B-574F-444C-9C5C-FBB158631C7B
P2860
Cancer chemoprevention: scientific promise, clinical uncertainty.
description
2005 nî lūn-bûn
@nan
2005 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Cancer chemoprevention: scientific promise, clinical uncertainty.
@ast
Cancer chemoprevention: scientific promise, clinical uncertainty.
@en
Cancer chemoprevention: scientific promise, clinical uncertainty.
@nl
type
label
Cancer chemoprevention: scientific promise, clinical uncertainty.
@ast
Cancer chemoprevention: scientific promise, clinical uncertainty.
@en
Cancer chemoprevention: scientific promise, clinical uncertainty.
@nl
prefLabel
Cancer chemoprevention: scientific promise, clinical uncertainty.
@ast
Cancer chemoprevention: scientific promise, clinical uncertainty.
@en
Cancer chemoprevention: scientific promise, clinical uncertainty.
@nl
P2860
P356
P1476
Cancer chemoprevention: scientific promise, clinical uncertainty.
@en
P2093
Karen T Liby
Michael B Sporn
P2860
P2888
P304
P356
10.1038/NCPONC0319
P577
2005-10-01T00:00:00Z
P5875
P6179
1051622618